Stock Day Media

Stock Day Media


The Stock Day Podcast Hosts CytoDyn to Discuss The Addition of Dr. Jonah Sacha to their Team

July 10, 2019

The Stock Day Podcast welcomed CytoDyn (CYDY)(“the Company”), a biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. CEO and President, Nader Pourhassan, Ph.D., joined Stock Day host Everett Jolly.